TrialBMC infectious diseases2016

No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects.

Lisa L Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.